Dopamine D1 antagonist SCH23390 attenuates self-administration of both cocaine and fentanyl in rats

Environmental Toxicology and Pharmacology

Volumn 3, Issue 2, 1997, Pages 115-122

  Awasaki, Yasuyuki ^a   Nishida, Nobuyuki ^a   Sasaki, Satoshi ^a   Sato, Shuzo ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Cocaine; Dopamine; Fentanyl; Progressive ratio; SCH23390; Self administration

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; FENTANYL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; INSTRUMENTAL CONDITIONING; INTRAVENOUS DRUG ADMINISTRATION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030961851     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(97)00147-6     Document Type: Article

References (30)

1. Bedford, J.A., L.P. Bailey and M.C. Wilson, 1978, Cocaine reinforced progressive ratio performance in the rhesus monkey, Pharmacol. Biochem. Behav. 9, 631.
2. Bozarth, M.A. and R.A. Wise, 1981, Heroin reward is dependent on a dopaminergic substrate, Life Sci. 29, 1881.
3. 2 receptors in maintaining cocaine self-administration, Pharmacol. Biochem. Behav. 39, 911.
4. Chiba, S., Y. Nakai and N. Nishida, 1981, An attempted application of the progressive ratio procedure in rats, Excerpta Medica Int. Congress Series 620, 231.
5. 1 antagonist SCH 23390 in comparison with neuroleptics, Life Sci. 34, 1529.
6. 2 dopamine antagonists, Pharmacol. Biochem. Behav. 39, 799.
7. Depoortere, R.Y., D.H. Li, J.D. Lane and M.W. Emmett-Oglesby, 1993, Parameters of self-administration of cocaine in rats under a progressive-ratio schedule, Pharmacol. Biochem. Behav. 45, 539.
8. Di Chiara, G. and A. Imperato, 1988a, Opposite effects of μ and κ opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats, J. Pharmacol. Exp. Ther. 244, 1067.
9. Di Chiara, G. and A. Imperato, 1988b, Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats, Proc. Natl. Acad. Sci. USA 85, 5274.
10. Di Chiara, G. and R.A. North, 1992, Neurobiology of opiate abuse, Trends Pharmacol. Sci. 13, 185.
11. Goeders, N.B., J.D. Lane and J.E. Smith, 1984, Self-administration of methionine enkephalin into the nucleus accumbens, Pharmacol. Biochem. Behav. 20, 451.
12. 1 dopamine receptor antagonist, in rat brain and blood, Psychopharmacology 106, 455.
13. Hoffmeister, F., 1979, Progressive-ratio performance in the rhesus monkey maintained by opiate infusions, Psychopharmacology 62, 181.
14. 2 dopamine antagonists on cocaine self-administration in the rat, Psychopharmacology 105, 151.
15. Kilts, C.D., K.L. Dew, T.D. Ely and R.B. Mailman, 1985, Quantification of R-(+)-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-methyl-3-benzazepine in brain and blood by use of reversed-phase high-performance liquid chromatography with electrochemical detection, J. Chromatogr. 342, 452
16. 1 dopamine receptor antagonist SCH23390 increases cocaine self-administration in the rat, Neurosci. lett. 79, 315.
17. Koob, G., 1992, Drugs of abuse: anatomy, pharmacology and function of reward pathways, Trends Pharmacol. Sci. 13, 177.
18. 1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning, Eur. J. Pharmacol. 135, 251.
19. 1 antagonists potentiate the durations of bar and cling catalepsy and the dorsal immobility response in rats, Pharmacol. Biochem. Behav. 41, 507.
20. Morelli, M., and G. Di Chiara, 1985, Catalepsy induced by SCH 23390 in rats, Eur. J. Pharmacol. 117, 179.
21. Pettit, H.O., A. Ettenberg, F.E. Bloom and G.F. Koob, 1984, Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats, Psychopharmacology 84, 167.
22. Roberts, D.C.S. and S.A.L. Bennett, 1993, Heroin self-administration in rats under a progressive ratio schedule of reinforcement, Psychopharmacology 111, 215.
23. Roberts, D.C.S. and G.F. Koob, 1982, Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats, Pharmacol. Biochem. Behav. 17, 901.
24. Smith, J.E., G.F. Guerin, C. Co, T.S. Barr and J.D. Lane, 1985, Effect of 6-OHDA lesion of the central medial nucleus accumbens on rat intravenous morphine self-administration, Pharmacol. Biochem. Behav. 23, 843
25. Spyraki, C., H.C. Fibiger, and A.G. Phillips, 1983, Attenuation of heroine reward in rats by disruption of mesolimbic dopamine system, Psychopharmacology 79, 278
26. Undie, A.S. and E. Friedman, 1988, Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics, Psychopharmacology 96, 311.
27. Van Ree, J.M. and N. Ramsey, 1987, The dopamine hypothesis of opiate reward challenged, Eur. J. Pharmacol. 134, 239.
28. Wise, R.A. and P.P. Rompre, 1989, Brain dopamine and reward, Annu. Rev. Psychol. 40, 191.
29. Wyatt, R.J., F. Karoum, R. Suddath and A. Hitri, 1988, The role of dopamine in cocaine use and abuse, Psychiatr. Ann. 18, 531.
30. Yanagita, T., 1980, Self-administration studies on psychological dependence, Trends Pharmacol. Sci. 1, 161.